Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 504 of 6351
-
New catheter aims to clear stroke clots faster
Disease control Recruiting nowThe purpose of this study is to assess the safety and the effectiveness of the Adaptive Tip Catheter (ATC) used as a first line direct aspiration thrombectomy technique for patients suffering of an acute ischemic stroke.
Sponsor: Neuravi Limited • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Engineered immune cells take on tough lung cancer
Disease control Recruiting nowThis study is an open-label, multi-center, adaptive Phase 1/2 trial evaluating the safety, feasibility, and preliminary antitumor activity of allogeneic dual-target CAR-NK cell products in adults with relapsed or refractory small cell lung cancer (SCLC). Three candidate dual-targ…
Phase 1/2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a High-Fat diet and therapy tame seizures in rare childhood epilepsy?
Disease control CompletedThis study evaluated the effects of medical ketogenic diet therapy combined with occupational therapy in children with ARX-related epilepsy. Twenty children were included. Ten children receiving a ketogenic diet formed the experimental group, and ten children not receiving a keto…
Sponsor: Uskudar University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New device could save lives by stopping severe bleeding in trauma patients
Disease control Not yet recruitingThis study seeks to evaluate the feasibility of a Abdominal Aortic Balloon Occlusion of the Aorta (AAJT-S) in exanguinating trauma patients with non-compressible truncal haemorrhage in the emergency room and the pre-hospital setting.
Sponsor: Medical University of Graz • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New drug aims to save lives from shock due to blood loss
Disease control Not yet recruitingThis protocol is designed to develop a novel first-in-class treatment for use in critical care and life-threatening condition of hypovolemic shock with unmet need and is of national interest. Shock is a life-threatening condition of circulatory failure. It is a state of cellular …
Phase 3 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Experimental cell therapy targets lung scarring in End-Stage disease
Disease control Not yet recruitingIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fatal interstitial lung disease characterized by irreversible scarring, leading to respiratory failure. With limited treatment options and a poor prognosis, new therapies are urgently needed. This study investigates a…
Phase 1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New drug cocktail aims to boost stroke recovery in mild cases
Disease control Recruiting nowAbstract Background Intravenous thrombolysis is the cornerstone of early treatment for acute ischemic stroke (AIS), but some still have a poor prognosis, especially in patients with mild disabling stroke. Tenecteplase (TNK), a novel thrombolytic agent with favorable pharmacokinet…
Phase 3 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a common antiviral save lives in advanced HIV?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if valganciclovir works to treat cytomegalovirus (CMV) infection in people with advanced HIV disease. It will also look at the safety of valganciclovir and how the body handles the drug. The main questions this study aims to answer are…
Phase 2 • Sponsor: Wits Health Consortium (Pty) Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New breathing support could save tiny lungs
Disease control Not yet recruitingRespiratory Distress Syndrome (RDS) remains the most common respiratory complication in the early postnatal period among preterm infants born before 32 weeks' gestational age. For this population, implementing lung-protective ventilation strategies is essential to shorten the dur…
Sponsor: Xingwang Zhu • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a brain pacemaker fight Alzheimer's? new trial begins.
Disease control Recruiting nowThe purpose of this study is to test a new procedure to treat Alzheimer's disease. The procedure is called intermittent Deep Brain Stimulation (DBS) of the nucleus basalis of Meynert. There will be up to six participants enrolled at Wellstar MCG Memory Clinic. There will be anoth…
Phase 1 • Sponsor: Augusta University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for pancreatic cancer: drug combo aims to shrink tumors before surgery
Disease control Not yet recruitingThis study is a Phase II trial evaluating the safety and efficacy of IBI343 in combination with chemotherapy as neoadjuvant therapy for subjects with borderline resectable pancreatic cancer (BRPC). The study enrolls treatment-naïve subjects with CLDN18.2-positive BRPC, confirmed …
Phase 2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for NMOSD attacks: immune drug added to standard care
Disease control Recruiting nowThis project is a multi-center, prospective, real-world cohort study that collects clinical data of Chinese patients with AQP4-positive NMOSD in the acute stage. It comprehensively assesses the clinical outcomes of the patients and aims to compare the clinical efficacy and safety…
Phase 4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug combo aims to keep High-Risk leukemia in remission before transplant
Disease control Recruiting nowThe goal of this clinical trial is to compare the efficacy and safety of a venetoclax-based consolidation therapy versus conventional consolidation chemotherapy in newly diagnosed adult patients with high-risk acute myeloid leukemia (AML) who have achieved complete remission (CR)…
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Heart-Saving pills? diabetes drugs tested to shield breast cancer patients from chemo damage
Prevention Not yet recruitingBackground: Breast cancer is the most frequently diagnosed malignancy among women worldwide and a major cause of morbidity and mortality. Anthracycline-based chemotherapy, particularly doxorubicin, remains a cornerstone of treatment; however, its clinical utility is limited by d…
Phase 4 • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New CAR-NK cell therapy takes on colorectal cancer
Disease control Recruiting nowThis Phase 1/2 study evaluates the safety, tolerability, and preliminary anti-tumor activity of an allogeneic dual-target chimeric antigen receptor natural killer (CAR-NK) cell product in adults with advanced or metastatic colorectal cancer (CRC). Participants are assigned to one…
Phase 1/2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Fasting diet and exercise may boost chemo in aggressive breast cancer
Disease control Recruiting nowLESLIE is a multicentric randomized controlled trial in patients with triple negative breast cancer receiving neoadjuvant chemo/immunotherapy (NAT). This trial investigates the hypothesis that adding a cyclic fasting-mimicking diet combined with exercise during the NAT improves t…
Phase 2 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Stent before surgery slashes deadly leak risk in colon patients
Prevention Recruiting nowRationale: Anastomotic leakage (AL) is a severe complication of colon surgery, with an incidence of 2.7-11.9%. It is associated with long-term increased mortality, reduced quality of life, and high healthcare costs due to reoperations and prolonged hospitalization. Among colon c…
Sponsor: Medisch Spectrum Twente • Aim: Prevention
Last updated Jul 29, 2026 00:00 UTC
-
Liver cancer surgery Follow-Up: could a targeted chemo shot keep cancer away?
Disease control Recruiting nowThe 5-year recurrence rate after curative hepatectomy of hepatocellular carcinoma (HCC) remains as high as 70%. According to the Chinese Liver Cancer Staging (CNLC), transarterial chemoembolization (TACE) is strongly recommended as an adjuvant therapy after curative hepatectomy, …
Phase 3 • Sponsor: Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New program aims to cut cervical cancer risk in vulnerable women
Prevention Recruiting nowCervical cancer (CC) remains one of the most common malignancies among women in India, with nearly 100,000 women diagnosed annually and over 60,000 preventable deaths annually. With high-risk human papillomavirus (HR-HPV) as the causative agent for CC, one risk factor that places…
Sponsor: University of California, Irvine • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Could steroids beat a deadly lung virus? new trial aims to find out
Disease control Not yet recruitingSevere community-acquired pneumonia caused by adenovirus (hereafter referred to as severe adenovirus pneumonia) is one of the common forms of severe community-acquired pneumonia in immunocompetent adults. It predominantly affects young individuals, progresses rapidly, and is asso…
Phase 3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC